Candid Therapeutics recorded San Diego’s largest venture capital deal during the third quarter. It was also the fourth largest deal in California.

The US IPO market is seeing renewed momentum as the 2024 presidential election approaches, with investors and analysts eyeing ...

We recently compiled a list of the 10 Most Promising Biotech Stocks According to Hedge Funds. In this article, we are going ...

We recently compiled a list of the 10 Most Promising Biotech Stocks According to Hedge Funds. In this article, we are going ...

We recently compiled a list of the 10 Most Promising Biotech Stocks According to Hedge Funds. In this article, we are going ...

The U.S.'s dominance in biotech innovation is critical to our national interests; yet, our government policies are ...

Promoters of SMT—the Kotadia family— plan to keep a minority stake after the transaction that would see other shareholders ...

Ceribell rang in a $180.3 million IPO last week, with its public debut on the Nasdaq coming in well above its first pricing ...

Geopolitical tensions, tightening foreign investment restrictions, and a poorly performing Chinese economy are some of the challenges facing private equity investors trying to exit their investments.

Marengo Asia Healthcare plans to expand its bed capacity to 3,000 by 2026 and may involve an external investor. The platform ...

Four IPOs each raised at least $75 million this week as the Fall IPO market continued to hum along, while one company ...